Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Jun;91(6):2880–2886. doi: 10.1172/JCI116533

Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection.

R Mantegazza 1, F Andreetta 1, P Bernasconi 1, F Baggi 1, J R Oksenberg 1, O Simoncini 1, M Mora 1, F Cornelio 1, L Steinman 1
PMCID: PMC443358  PMID: 8514895

Abstract

Polymyositis is an inflammatory myopathy characterized by mononuclear cell infiltration of muscle tissue. Myocytotoxic T lymphocytes have been recognized in the infiltrates, but the muscle antigen, target of the immune attack, has not been identified. Molecular characterization of the variable regions of T cell receptors (TCRs) on the infiltrating lymphocytes can be expected to provide insights into the pathogenic process. The V alpha/beta TCR repertoire was investigated by RNA-PCR in muscle biopsies from 15 polymyositis patients and 16 controls (6 Duchenne muscular dystrophy and 10 with no inflammatory or dystrophic myopathy). A variety of rearranged variable TCR genes was found in polymyositis, V alpha 1, V alpha 5, V beta 1, and V beta 15 being the most common (present in 60-100% of patients). In Duchenne muscular dystrophy patients TCR V alpha or beta rearrangements were found although no restriction was observed; no rearrangements were found in muscles from the other controls. Sequence analysis revealed the presence of the J beta 2.1 region in 90% of the V beta 15 clones studied, no random N additions in the diversity region, and a common motif within the CDR3 region. These results suggest that selection of muscle-infiltrating T lymphocytes is antigen driven in polymyositis.

Full text

PDF
2880

Images in this article

2882Image
on p.2882
2882Image
on p.2882
2882Image
on p.2882
2882Image
on p.2882
2882Image
on p.2882
2882Image
on p.2882
2883Image
on p.2883
2883Image
on p.2883
2883Image
on p.2883
2883Image
on p.2883
2883Image
on p.2883
2883Image
on p.2883
2883Image
on p.2883
2883Image
on p.2883
2884Image
on p.2884
2884Image
on p.2884
2884Image
on p.2884
2884Image
on p.2884
2884Image
on p.2884
2884Image
on p.2884
2884Image
on p.2884
2884Image
on p.2884

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acha-Orbea H., Mitchell D. J., Timmermann L., Wraith D. C., Tausch G. S., Waldor M. K., Zamvil S. S., McDevitt H. O., Steinman L. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 1988 Jul 15;54(2):263–273. doi: 10.1016/0092-8674(88)90558-2. [DOI] [PubMed] [Google Scholar]
  2. Appleyard S. T., Dunn M. J., Dubowitz V., Rose M. L. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Lancet. 1985 Feb 16;1(8425):361–363. doi: 10.1016/s0140-6736(85)91384-4. [DOI] [PubMed] [Google Scholar]
  3. Arahata K., Engel A. G. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol. 1984 Aug;16(2):193–208. doi: 10.1002/ana.410160206. [DOI] [PubMed] [Google Scholar]
  4. Arahata K., Engel A. G. Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol. 1988 Feb;23(2):168–173. doi: 10.1002/ana.410230210. [DOI] [PubMed] [Google Scholar]
  5. Arahata K., Engel A. G. Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells. Ann Neurol. 1988 May;23(5):493–499. doi: 10.1002/ana.410230511. [DOI] [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Chothia C., Boswell D. R., Lesk A. M. The outline structure of the T-cell alpha beta receptor. EMBO J. 1988 Dec 1;7(12):3745–3755. doi: 10.1002/j.1460-2075.1988.tb03258.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dalakas M. C. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991 Nov 21;325(21):1487–1498. doi: 10.1056/NEJM199111213252107. [DOI] [PubMed] [Google Scholar]
  9. Emslie-Smith A. M., Arahata K., Engel A. G. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol. 1989 Mar;20(3):224–231. doi: 10.1016/0046-8177(89)90128-7. [DOI] [PubMed] [Google Scholar]
  10. Engel A. G., Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol. 1984 Aug;16(2):209–215. doi: 10.1002/ana.410160207. [DOI] [PubMed] [Google Scholar]
  11. Goebels N., Michaelis D., Wekerle H., Hohlfeld R. Human myoblasts as antigen-presenting cells. J Immunol. 1992 Jul 15;149(2):661–667. [PubMed] [Google Scholar]
  12. Hohlfeld R., Engel A. G., Ii K., Harper M. C. Polymyositis mediated by T lymphocytes that express the gamma/delta receptor. N Engl J Med. 1991 Mar 28;324(13):877–881. doi: 10.1056/NEJM199103283241303. [DOI] [PubMed] [Google Scholar]
  13. Hohlfeld R., Engel A. G. Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am J Pathol. 1990 Mar;136(3):503–508. [PMC free article] [PubMed] [Google Scholar]
  14. Iyer V., Lawton A. R., Fenichel G. M. T-cell subsets in polymyositis. Ann Neurol. 1983 Apr;13(4):452–453. doi: 10.1002/ana.410130413. [DOI] [PubMed] [Google Scholar]
  15. Jorgensen J. L., Esser U., Fazekas de St Groth B., Reay P. A., Davis M. M. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature. 1992 Jan 16;355(6357):224–230. doi: 10.1038/355224a0. [DOI] [PubMed] [Google Scholar]
  16. Karpati G., Pouliot Y., Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol. 1988 Jan;23(1):64–72. doi: 10.1002/ana.410230111. [DOI] [PubMed] [Google Scholar]
  17. Kimura N., Toyonaga B., Yoshikai Y., Triebel F., Debre P., Minden M. D., Mak T. W. Sequences and diversity of human T cell receptor beta chain variable region genes. J Exp Med. 1986 Sep 1;164(3):739–750. doi: 10.1084/jem.164.3.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Leff R. L., Love L. A., Miller F. W., Greenberg S. J., Klein E. A., Dalakas M. C., Plotz P. H. Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle. Lancet. 1992 May 16;339(8803):1192–1195. doi: 10.1016/0140-6736(92)91134-t. [DOI] [PubMed] [Google Scholar]
  19. Leon-Monzon M., Dalakas M. C. Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies. Ann Neurol. 1992 Aug;32(2):219–222. doi: 10.1002/ana.410320215. [DOI] [PubMed] [Google Scholar]
  20. Mantegazza R., Hughes S. M., Mitchell D., Travis M., Blau H. M., Steinman L. Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma. Neurology. 1991 Jul;41(7):1128–1132. doi: 10.1212/wnl.41.7.1128. [DOI] [PubMed] [Google Scholar]
  21. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
  22. Mastaglia F. L., Ojeda V. J. Inflammatory myopathies: Part 1. Ann Neurol. 1985 Mar;17(3):215–227. doi: 10.1002/ana.410170302. [DOI] [PubMed] [Google Scholar]
  23. Mastaglia F. L., Ojeda V. J. Inflammatory myopathies: Part 2. Ann Neurol. 1985 Apr;17(4):317–323. doi: 10.1002/ana.410170402. [DOI] [PubMed] [Google Scholar]
  24. McDouall R. M., Dunn M. J., Dubowitz V. Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci. 1989 Feb;89(2-3):213–226. doi: 10.1016/0022-510x(89)90023-3. [DOI] [PubMed] [Google Scholar]
  25. Moebius U., Manns M., Hess G., Kober G., Meyer zum Büschenfelde K. H., Meuer S. C. T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones. Eur J Immunol. 1990 Apr;20(4):889–896. doi: 10.1002/eji.1830200426. [DOI] [PubMed] [Google Scholar]
  26. Offner H., Hashim G. A., Vandenbark A. A. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science. 1991 Jan 25;251(4992):430–432. doi: 10.1126/science.1989076. [DOI] [PubMed] [Google Scholar]
  27. Oksenberg J. R., Panzara M. A., Begovich A. B., Mitchell D., Erlich H. A., Murray R. S., Shimonkevitz R., Sherritt M., Rothbard J., Bernard C. C. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 1993 Mar 4;362(6415):68–70. doi: 10.1038/362068a0. [DOI] [PubMed] [Google Scholar]
  28. Oksenberg J. R., Stuart S., Begovich A. B., Bell R. B., Erlich H. A., Steinman L., Bernard C. C. Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature. 1990 May 24;345(6273):344–346. doi: 10.1038/345344a0. [DOI] [PubMed] [Google Scholar]
  29. Panzara M. A., Gussoni E., Steinman L., Oksenberg J. R. Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers. Biotechniques. 1992 May;12(5):728–735. [PubMed] [Google Scholar]
  30. Pluschke G., Rüegg D., Hohlfeld R., Engel A. G. Autoaggressive myocytotoxic T lymphocytes expressing an unusual gamma/delta T cell receptor. J Exp Med. 1992 Dec 1;176(6):1785–1789. doi: 10.1084/jem.176.6.1785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Steinman L., Mantegazza R. Prospects for specific immunotherapy in myasthenia gravis. FASEB J. 1990 Jul;4(10):2726–2731. doi: 10.1096/fasebj.4.10.2197152. [DOI] [PubMed] [Google Scholar]
  33. Urban J. L., Kumar V., Kono D. H., Gomez C., Horvath S. J., Clayton J., Ando D. G., Sercarz E. E., Hood L. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell. 1988 Aug 12;54(4):577–592. doi: 10.1016/0092-8674(88)90079-7. [DOI] [PubMed] [Google Scholar]
  34. Williams W. V., Fang Q., Demarco D., VonFeldt J., Zurier R. B., Weiner D. B. Restricted heterogeneity of T cell receptor transcripts in rheumatoid synovium. J Clin Invest. 1992 Aug;90(2):326–333. doi: 10.1172/JCI115866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wolf R. E., Baethge B. A. Interleukin-1 alpha, interleukin-2, and soluble interleukin-2 receptors in polymyositis. Arthritis Rheum. 1990 Jul;33(7):1007–1014. doi: 10.1002/art.1780330713. [DOI] [PubMed] [Google Scholar]
  36. Wraith D. C., McDevitt H. O., Steinman L., Acha-Orbea H. T cell recognition as the target for immune intervention in autoimmune disease. Cell. 1989 Jun 2;57(5):709–715. doi: 10.1016/0092-8674(89)90786-1. [DOI] [PubMed] [Google Scholar]
  37. Wucherpfennig K. W., Ota K., Endo N., Seidman J. G., Rosenzweig A., Weiner H. L., Hafler D. A. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science. 1990 May 25;248(4958):1016–1019. doi: 10.1126/science.1693015. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES